Response to highly active antiretroviral therapy in HIV-infected patients aged 60 years or older after 24 months follow-up

The study of elderly persons with HIV disease is of interest for two reasons: the low prevalence of AIDS in individuals aged 60 years or older, and the fact that epidemiological evidence has mostly been collected before the introduction of highly active antiretroviral therapy (HAART). It seems that...

Full description

Saved in:

Bibliographic Details
Published in:	AIDS (London) Vol. 15; no. 12; pp. 1591 - 1593
Main Authors:	Knobel, H, Guelar, A, Valldecillo, G, Carmona, A, González, A, López-Colomés, J L, Saballs, P, Gimeno, J L, Díez, A
Format:	Journal Article
Language:	English
Published:	England 17-08-2001
Subjects:	Adult Age Factors Aged Aging - physiology AIDS/HIV Antiretroviral Therapy, Highly Active CD4 Lymphocyte Count Female highly active antiretroviral therapy HIV Infections - drug therapy HIV Infections - immunology HIV Infections - mortality Human immunodeficiency virus Humans Male Treatment Outcome
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Description
Summary:	The study of elderly persons with HIV disease is of interest for two reasons: the low prevalence of AIDS in individuals aged 60 years or older, and the fact that epidemiological evidence has mostly been collected before the introduction of highly active antiretroviral therapy (HAART). It seems that an aggressive therapeutic approach is warranted for older patients with HIV disease. We compared the response to first-line HAART in patients aged 60 years or older and patients aged 40 years or less.
Bibliography:	ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-1 content type line 23 SourceType-Other Sources-1 content type line 63 ObjectType-Correspondence-1
ISSN:	0269-9370
DOI:	10.1097/00002030-200108170-00025